AKTIENANLEIHE - ADIDAS/PUMA/NIKE `B` Stock

Certificat

DE000VM9KRA2

Real-time Bid/Ask 09:21:59 2024-05-17 am EDT
98.38 EUR / 99.38 EUR +0.44% Intraday chart for AKTIENANLEIHE - ADIDAS/PUMA/NIKE `B`
Current month-0.01%
1 month+1.79%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 98.27 -0.18%
24-05-16 98.45 -0.51%
24-05-15 98.95 +0.15%
24-05-14 98.8 +0.92%
24-05-13 97.9 -0.94%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 02:49 am EDT

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying NIKE, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9KRA
ISINDE000VM9KRA2
Date issued 2024-02-26
Strike 88.86 $
Maturity 2024-11-15 (182 Days)
Parity 0.09 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 100
Lowest since issue 96.04
Spread 10
Spread %1.01%

Company Profile

Nike, Inc. specializes in the design, manufacturing and marketing of sports shoes, clothing, and equipment. The group's products are sold primarily under the names Nike, Jordan, Converse Chuck Taylor, All Star, One Star, Star Chevron and Jack Purcell. Net sales break down by family of products as follows: - footwear (68.9%); - clothing (27.2%); - sports equipment (3.4%): golf equipment (golf clubs, balls, gloves, etc.), bags, balls, etc.; - other (0.5%). At the end of May 2023, products were being marketed through a network of 1,032 stores worldwide, through independent distributors, and via the Internet. Net sales are distributed geographically as follows: North America (44.3%), Europe/Middle East/Africa (27.5%), China (14.9%), Asia/Pacific and Latin America (13.2%) and other (0.1%).
Sector
-
More about the company

Ratings for Nike, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Nike, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
91.77 USD
Average target price
111.3 USD
Spread / Average Target
+21.23%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW